(Q80479295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Survival and erythropoietin receptor protein in tumours from patients randomly treated with rhEPO for palliative care (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Christina Lönnroth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Marie Svensson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Wenhua Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ulla Körner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Peter Daneryd

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ola Nilsson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

11 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

22-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18188711%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12032-007-9001-7

31 December 2019

exact match

0 references

cites work

The erythropoietin-receptor pathway modulates survival of cancer cells.

1 reference

12 December 2020

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

12 December 2020

Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas

1 reference

12 December 2020

Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies

1 reference

12 December 2020

Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib

1 reference

12 December 2020

Erythropoietin may impair, not improve, cancer survival

1 reference

12 December 2020

Indomethacin and telomerase activity in tumor growth retardation

1 reference

12 December 2020

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

1 reference

12 December 2020

Erythropoietin: physiology and pharmacology update

1 reference

12 December 2020

Expression of erythropoietin receptor splice variants in human cancer.

1 reference

12 December 2020

New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications

1 reference

12 December 2020

Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.

1 reference

12 December 2020

Pediatric Tumor Cells Express Erythropoietin and a Functional Erythropoietin Receptor that Promotes Angiogenesis and Tumor Cell Survival

1 reference

12 December 2020

Cloning and expression of the human erythropoietin gene

1 reference

12 December 2020

Functional significance of erythropoietin receptor expression in breast cancer

1 reference

12 December 2020

Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer.

1 reference

12 December 2020

Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients

1 reference

12 December 2020

Erythropoietin regulates tumour growth of human malignancies

1 reference

12 December 2020

Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator

1 reference

12 December 2020

Prognostic significance of erythropoietin expression in human endometrial carcinoma

1 reference

12 December 2020

Factors influencing quality of life in cancer patients: anemia and fatigue.

1 reference

12 December 2020

Erythroid progenitors differentiate and mature in response to endogenous erythropoietin

1 reference

12 December 2020

Isolation and characterization of genomic and cDNA clones of human erythropoietin

1 reference

12 December 2020

Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer

1 reference

12 December 2020

Cyclooxygenase inhibition in early onset of tumor growth and related angiogenesis evaluated in EP1 and EP3 knockout tumor-bearing mice.

1 reference

12 December 2020

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma.

1 reference

12 December 2020

Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy.

1 reference

12 December 2020

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

1 reference

12 December 2020

Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.

1 reference

12 December 2020

Functional erythropoietin autocrine loop in melanoma

1 reference

12 December 2020

Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors.

1 reference

12 December 2020

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

12 December 2020

1 reference

12 December 2020

Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function

1 reference

12 December 2020

The erythropoietin receptor and its expression in tumor cells and other tissues

1 reference

12 December 2020

Erythropoietin and erythropoietin receptor expression in human cancer.

1 reference

12 December 2020

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

12 December 2020

Erythropoietin as an angiogenic factor in gastric carcinoma

1 reference

12 December 2020

Anti-Epo receptor antibodies do not predict Epo receptor expression

1 reference

12 December 2020